Overview

A Dose-escalation Study of the Safety and Tolerability of Orally Administered TG101348 in Patients With Myelofibrosis

Status:
Completed

Trial end date:
2009-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and tolerability of orally administered TG101348 in patients with myelofibrosis.

Phase:

Phase 1

Details

Lead Sponsor:

TargeGen